Expert Perspectives on the Clinical Use of Steroids for Various Ocular Inflammatory Conditions in Indian Settings

Manjula S *

Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India.

Krishna Kumar M

Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India.

*Author to whom correspondence should be addressed.


Background: Although there were clinical studies available regarding the usage of steroids, there were lack of data from clinician’s perspectives. This survey was intended to gather expert perspectives regarding the prescription practice and clinical use of steroids, including specific types and their applications in various inflammatory ocular conditions, as well as in post-cataract surgeries.

Methods: This cross-sectional study comprised of 26 multiple-response questionnaires about expert perspectives on steroid prescription practices for ocular conditions and post-cataract surgeries. The survey also collected data on cataract surgery frequency, geographic distribution of cataract development, gender prevalence, and awareness of ocular health in rural and urban populations. Data analysis was conducted using descriptive statistics.

Results: The study involved 103 ophthalmic experts in India and majority of the clinicians (36.89%) conducted over 50 cataract surgeries per month, with cataract development reported as most prevalent in suburban (37%) and urban (35%) areas. Most respondents (82.52%) indicated equal prevalence of cataract in both genders, with a higher occurrence observed in patients aged 51-60 years (49.51%). Prednisolone was the preferred steroid after cataract surgery among 64% of the clinicians and for treating anterior (53%) and posterior (64%) segment inflammatory conditions. A substantial proportion of clinicians (46.6%) reported starting non-steroidal anti-inflammatory (NSAID) therapy along with steroids in 21-30% of their patients for managing post-operative inflammation. Most of the experts recommended nepafenac (85%) as the most effective medication for controlling cystoid macular edema (CME).

Conclusion: The study highlighted the use of prednisolone as the preferred steroid after cataract surgery and for various inflammatory conditions. Loteprednol emerged as a favored choice for ocular surface inflammation and allergy-associated conditions, while nepafenac was recommended for controlling CME.

Keywords: Steroids, prednisolone, cataract surgery, cystoid macular edema

How to Cite

Manjula S, and Krishna Kumar M. 2024. “Expert Perspectives on the Clinical Use of Steroids for Various Ocular Inflammatory Conditions in Indian Settings”. Asian Journal of Research and Reports in Ophthalmology 7 (1):120-28.


Download data is not yet available.


Lee CM, Afshari NA. The global state of cataract blindness. Current Opinion in Ophthalmology. 2017 Jan;28(1):98.

Fang R, Yu YF, Li EJ, Lv NX, Liu ZC, Zhou HG, et al. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019. BMC Public Health. 2022 Nov 12;22(1):2068.

Vashist P, Talwar B, Gogoi M, Maraini G, Camparini M, Ravilla R, et al. Prevalence of cataract in an older population in India the India study of age-related eye disease. Ophthalmology. 2011 Feb 1;118:272-8.e1.

Bali J, Bali O, Sahu A, Boramani J, Senthil T, Deori N. State of the nation survey on cataract surgery in India. Indian J Ophthalmol. 2022 Nov;70(11):3812–7.

Clare G, Kempen JH, Pavésio C. Infectious eye disease in the 21st century-an overview. Eye (Lond). 2024 Feb 14. Epub ahead of print. PMID: 38355671.

Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021 Jun;11(3):866–93.

Puckett Y, Gabbar A, Bokhari AA. Prednisone. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 May 16]. Available:

Sobti S, Sahni B, Bala K. Surgical coverage of cataract in a rural area of north India: A cross-sectional study. J Family Med Prim Care. 2020 Aug 25;9(8):4112–7.

Dandona L, Dandona R, Anand R, Srinivas M, Rajashekar V. Outcome and number of cataract surgeries in India: policy issues for blindness control. Clin Exp Ophthalmol. 2003 Feb;31(1):23–31.

Singh S, Pardhan S, Kulothungan V, Swaminathan G, Ravichandran JS, Ganesan S, et al. The prevalence and risk factors for cataract in rural and urban India. Indian Journal of Ophthalmology. 2019 Apr;67(4):477.

Malik A, Sadafale A, Gupta YK, Gupta A. A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation. Oman J Ophthalmol. 2016;9(3):150–6.

Panda B, Nanda A, Swain S. Therapeutic Efficacy of Difluprednate 0.05% Versus Prednisolone Acetate 1% in Controlling Inflammation and Macular Oedema Following Phacoemulsification: An Optical Coherence Tomography-Based Study. Cureus. 2021 Apr 25;13:e14673.

Prednisolone Acetate - an overview. ScienceDirect Topics [Internet]. Available: [cited on May 16, 2024].

Comstock TL, Sheppard JD. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. Expert Opinion on Pharmacotherapy. 2018 Mar 4;19(4):337–53.

Vidyadevi M, Anuradha A, Rashmi G, Shilpa R, Nishath S. Safety of Fixed drug Combination in Post –Operative Cataract Patients, at Tertiary Care Centre – In South India. Nepalese Journal of Ophthalmology. 2017 Jun 20;9:24.

Haddad JE, Sabbakh NA, Macaron MM, Shaaban H, Bourdakos NE, Shi A, et al. NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis. American Journal of Ophthalmology. 2024 Apr 1;260:1–13.

Hariprasad SM, Akduman L, Clever JA, Ober M, Recchia FM, Mieler WF. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Clin Ophthalmol. 2009;3: 147–54.

El Gharbawy SA, Darwish EA, Abu Eleinen KG, Osman MH. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes. European Journal of Ophthalmology. 2019 Jul 1;29(4):453–7.

Mohamed AI, Nassar E-SA, Elsoht RM, Shaheen MA. Ocular Surface Alterations Related to Cataract Surgery. J. Adv. Med. Med. Res. [Internet]. 2023 Feb. 2 [cited 2024 May 18];35(2):50-6.


Jeneral AR. Clinical Outcomes of Surgery for Age-related Cataract with Intraocular Lens Implantation in Two Hospitals in North-Central Nigeria. Ophthalmol. Res. Int. J. [Internet]. 2023 Jun. 27 [cited 2024 May 18];18(4):1-10. Available:

Abdalla Elsayed ME, Ahmad K, Al-Abdullah AA, Malik R, Khandekar R, Martinez-Osorio H, Mura M, Schatz P. Incidence of intraocular lens exchange after cataract surgery. Scientific reports. 2019 Sep 9;9(1):12877.